Endocrine Today Current Issue

The following articles appeared in the print edition of Endocrine Today.

Table of Contents

• Type 1 diabetes screening reaches ‘potentially pivotal moment’ with new treatment option Melissa Foster
• Beyond insulin: ‘Multiple strategies’ needed to improve outcomes in type 1 diabetes Regina Schaffer
• Cancer history does not affect survival odds for adults with anaplastic thyroid carcinoma Michael Monostra
• Consensus statement on thyroid eye disease focuses on new therapies, individualized care Michael Monostra
• Fatty liver disease conditions ‘change the healthy heart to a failing heart’ Regina Schaffer
• Fatty pancreas increases diabetes risk, but may be reversible with weight loss Michael Monostra
• FDA approves abaloparatide for men with osteoporosis at high risk for fracture
• Healthy management of type 1 diabetes in pregnancy begins before conception Susan Weiner, MS, RDN, CDN, CDCES, FADCES; Jennifer Smith, RD, LD, CDCES
• Irregular, long menstrual cycles may be indicative of future CVD Scott Buzby
• Many hospital providers not familiar with policies, use of diabetes technology Michael Monostra
• Mindfulness may offer an ‘appealing approach’ to lower blood pressure Katie Kalvaitis
• NAFLD ‘not fit for purpose’: Experts debate impact of changing name vs. definition Monica Stonehill
• Next-generation Dexcom G7 CGM receives FDA clearance for use in type 1 and type 2 diabetes
• Pemafibrate lowers triglycerides but not CV events in type 2 diabetes, mixed dyslipidemia Katie Kalvaitis
• Presence of type 2 diabetes in acromegaly increases mortality and morbidity risks Erin T. Welsh, MA
• Prevalence of pregestational diabetes increased since 2000, increases pregnancy risks Kalie VanDewater
• Q&A: Consensus criteria, education could boost pancreas transplantation uptake in diabetes Michael Monostra
• Sotagliflozin reduces 30-day HF readmission rates in type 2 diabetes Regina Schaffer
• ‘Stand up, speak up’ to increase female representation in trial leadership Regina Schaffer
• Statin therapy ‘vastly superior’ to common dietary supplements for cholesterol lowering Regina Schaffer
• Subclinical hyperthyroidism independent risk factor for fracture Erin T. Welsh, MA
• US regional variations seen in hormonal, metabolic profiles in polycystic ovary syndrome Erin T. Welsh, MA
• ‘ZIP code matters’: COVID-19 hospitalizations, CV outcomes differ by where people live Regina Schaffer
• Endocrinology Drug and Device Update Jill Rollet
• GnRHa use not linked to increased gender-affirming hormone use by transgender youths Erin T. Welsh, MA
• Is universal screening for type 1 diabetes ready for prime time? Melissa Foster